⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 28, 2016World Journal of Surgical OncologyOpen Access

Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer

Jun Li Yuemin Ding Aiqing Li

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

We find that COL1A1 might have its potential as a monitoring factor to screen early gastric cancer, and COL1A1 and COL1A2 might predict poor clinical outcomes in gastric cancer patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2016) studied this question.

synapsesocial.com/papers/69dc49155e1d727a1a274883 https://doi.org/10.1186/s12957-016-1056-5

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012Cohort Study · 2014 · 29,370 citations
2Outcome of gastric cancer patients after successful gastrectomyRetrospective Study · 2006 · 49 citations
3The Fibrillar Collagen FamilyReview · 2010 · 309 citations
4Identification of Novel Target Genes by an Epigenetic Reactivation Screen of Renal CancerOriginal Research · 2006 · 154 citations
5Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinomaGenetic Association Study · 2014 · 101 citations
6Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in MelanomaOriginal Research · 2011 · 85 citations
7Identification of Differentially-Expressed Genes in Intestinal Gastric Cancer by Microarray AnalysisOriginal Research · 2014 · 18 citations
8Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancerPrognostic Study · 2012 · 40 citations
9Gemcitabine plus cisplatin versus gemcitabine as adjuvant therapy after curative-intent resection of cholangiocarcinoma (GeCiCCA): a multicenter, randomized controlled, phase III trialWorld Journal of Surgical Oncology · 2026
10The Mayo Adhesive Probability score as a predictor of surgical outcomes in adrenalectomy: a systematic review and meta-analysisWorld Journal of Surgical Oncology · 2026

More from World Journal of Surgical Oncology

More from Zhejiang University

More from Sir Run Run Shaw Hospital

More from Jiyang College of Zhejiang A&F University